Pharma News
Last update 23 Oct 2026
#sun pharma
2 stories tagged "sun pharma".
Advertise Here
Reach qualified buyersBoost your visibility among pharma sourcing professionals and potential buyers.
- Grow your business with qualified leads
- GDS reports on your ad performance
- Targeted to this product's audience
- Direct enquiries from buyers
- Visibility to pharma professionals
Industry News23 Oct 2026
Sun Pharma to present long-term cancer drug data at ESMO 2026
UNLOXCYT was approved by the US Food and Drug Administration (FDA) in 2024 for adults with metastatic or locally advanced cutaneous squamous cell carcinoma
Indianpharmapost•23 Oct 2026
•1 min read
Read story
Latest news
Showing 1–2 of 2 stories
Sun Pharma’s UNLOXCYT gets NCCN Category 2A recommendation for locally advanced skin cancer
The updated recommendation adds to the drug’s existing Category 2A designation for metastatic cutaneous squamous cell carcinoma
Indianpharmapost•
20 Oct 2026
•1 min read
Read story
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
- 30 days of free advertising
- Visibility across all pages
- Performance report with ad insights
- No setup or registration fee
Exclusive introductory offer for new advertisers
Top sources
A
Abnewswire
10 stories
I
Indianpharmapost
5 stories
F
Finanznachrichten.de
5 stories
K
Kalkine Media
4 stories
F
FDA
4 stories
Post your requirement
Get offers from suppliers
- Reach pharmaceutical suppliers
- Specify quality standard and quantity
- Set your shipping preference
- Receive offers directly
- Listed on our marketplace
Your product details and requirements may be published on the marketplace.
Create a New Buying Request
Fields marked with * are mandatory.